Gabapentin Capsule
Product Images NDC 80425-0163

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0163). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

A line graph comparing mean pain scores over an 8-week period between a placebo group and a gabapentin 3600 mg/day group. The x-axis shows weeks from baseline to 8, and the y-axis shows mean pain scores from 0 to 10. The graph includes a 4-week dose titration period followed by a 4-week fixed dose period. Gabapentin shows a decreasing pain score trend, while placebo remains relatively stable.*

FDA Label Image

Fig 2

A line graph depicting mean pain scores over a 7-week period, including a 3-week dose titration phase and a 4-week fixed dose phase. It compares three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day, with pain scores plotted on the vertical axis and weeks on the horizontal axis.*

FDA Label Image

Fig 3

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) treatments in two studies. Study 1 shows 12% responders for placebo and 29% for GBP 3600 mg. Study 2 shows 14% responders for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance indicators are noted for comparisons.*

FDA Label Image

Fig 4

A plot showing percent difference on the y-axis against daily dose (mg) on the x-axis for Gabapentin capsules. Data points represent three separate studies labeled a, b, and c, with daily doses at approximately 600, 900, 1200, and 1800 mg. Study a is indicated by black squares, study b by gray squares, and study c by white squares. The graph compares the variations in percent difference across doses and studies.*

FDA Label Image

Formula

A text panel showing a formula to calculate creatinine clearance (CLCr) based on age, weight, serum creatinine, and a factor for female patients. This mathematical expression provides guidance for renal function estimation related to drug dosing.*

FDA Label Image

Gabapentin 400mg Tab Qty 90 Ndc 80425 0163

Label for Gabapentin 400 mg capsules, package count 90, labeled by Advanced Rx Pharmacy of Tennessee, LLC in Nashville, TN. The label includes NDC 80425-0163 and source NDC 06777-0224-05, with lot number 90GAB4001221 and expiration date 01/2022. Storage instructions specify room temperature 20°-25°C (68°-77°F).*

FDA Label Image

Structure

Chemical structure of Gabapentin depicted as a cyclohexane ring with side chains including an amino group (CH2NH2) and a carboxyl group (CH2CO2H).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.